We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA ISSUES WARNING LETTERS ABOUT ANDROSTENEDIONE
FDA ISSUES WARNING LETTERS ABOUT ANDROSTENEDIONE
March 12, 2004
The FDA has issued warning letters to 23 companies that manufacture and distribute products containing androstenedione, a steroid precursor that has become popular among professional and amateur athletes.